VVOS logo

Vivos Therapeutics (VVOS)

Profile

Full Name

Vivos Therapeutics, Inc.

Ticker Symbol

VVOS

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

December 11, 2020

Indexes

Not included

Website

http://www.vivos.com

Employees

109

Key Details

Price

$2.33(+1.75%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$15.03M(+8.91% YoY)

Annual EPS

-$2.22(+80.07% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.33
VVOS price is $2.33

30-Day Relative Volume

0.47
VVOS 30-day relative volume is 0.47

Price Performance

Price Most recent change

+1.75%
VVOS price was up +1.75% on Apr 11, 2025

Price YTD change

-45.69%
VVOS price is down -45.69% since January 1st

Price 1-year change

-14.96%
VVOS price is down -14.96% year-on-year

Price 3-year change

-95.27%
VVOS price is down -95.27% over the past 3 years

Price Range

Price All-time high

$360.25
VVOS price is currently -99.35% below its historical high of $360.25

Price 3-year low

$1.91
VVOS price is currently +21.99% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$13.72M
VVOS market capitalization is $13.72 million

Market cap 3-year change

-69.73%
VVOS market capitalization is down -69.73% over the past 3 years

Market cap All-time high

$176.11M
VVOS market capitalization is currently -92.21% below its historical high of $176.11 million

Market cap sector rank

24.24%
VVOS market capitalization is higher than 24.24% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+97.48%
VVOS shares outstanding is up +97.48% year-on-year

Shares Outstanding 3-Year Change

+539.82%
VVOS shares outstanding is up +539.82% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.89
VVOS beta is 0.89

200-day SMA

$3.23
VVOS price is currently -27.81% below its 200-day simple moving average

50-day SMA

$3.35
VVOS price is currently -30.52% below its 50-day simple moving average

RSI

32.42
VVOS 14-day relative strength index is 32.42

Volume

0.47
VVOS 30-day relative volume is 0.47

ATR

$0.30
VVOS average true range is $0.30

10-day Historical Volatility

103.99%
VVOS 10-day historical volatility is 103.99%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$15.03M
VVOS annual revenue is $15.03 million

Revenue Analysts estimate

$18.00M
VVOS annual revenue is currently -16.49% lower than the consensus analysts' forecast

Revenue 1-year change

+8.91%
VVOS annual revenue is up +8.91% year-on-year

Revenue Sector rank

32.36%
VVOS annual revenue is higher than 32.36% of companies in Healthcare sector

EPS

EPS

-$2.22
VVOS annual earnings per share is -$2.22

EPS Analysts estimate

-$1.00
VVOS annual earnings per share is currently +122.00% higher than the consensus analysts' forecast

EPS 1-year change

+80.07%
VVOS annual earnings per share is up +80.07% year-on-year

EPS Sector rank

36.42%
VVOS annual earnings per share is higher than 36.42% of companies in Healthcare sector

Profit

Gross profit

$9.02M
VVOS annual gross profit is $9.02 million

Gross margin

60.00%
VVOS annual gross profit margin is 60.00%

Operating profit

-$11.17M
VVOS annual operating income is -$11.17 million

Operating margin

-74.32%
VVOS annual operating profit margin is -74.32%

Net income

-$11.14M
VVOS annual net profit is -$11.14 million

Net margin

-74.09%
VVOS annual net profit margin is -74.09%

Expenses

Total expenses

$26.20M
VVOS annual total expenses is $26.20 million

Operating expenses

$20.19M
VVOS annual total operating expenses is $20.19 million

Cost of goods sold

$6.01M
VVOS annual cost of goods sold is $6.01 million

Selling, general & administrative expenses

$19.61M
VVOS annual SGA is $19.61 million

Depreciation and amortization

$581.00K
VVOS annual depreciation & amortization is $581.00 thousand

Interest expense

-
VVOS annual interest expense value is unknown

Income tax

-
VVOS annual income tax value is unknown

EBIT & EBITDA

EBIT

-$11.17M
VVOS annual earnings before interest & taxes is -$11.17 million

EBITDA

-$10.59M
VVOS annual EBITDA is -$10.59 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$15.28M
VVOS annual total assets is $15.28 million

Non current assets

$7.81M
VVOS annual long term assets is $7.81 million

Current assets

$7.47M
VVOS annual total current assets is $7.47 million

Cash and cash equivalents

$6.26M
VVOS annual cash & cash equivalents is $6.26 million

Accounts receivable

$430.00K
VVOS annual accounts receivable is $430.00 thousand

Inventory

-
VVOS annual inventory value is unknown

Liabilities

Total liabilities

$7.33M
VVOS annual total liabilities is $7.33 million

Long term liabilities

$2.35M
VVOS annual total long term liabilities is $2.35 million

Current liabilities

$4.98M
VVOS annual total current liabilities is $4.98 million

Accounts payable

$1.10M
VVOS annual accounts payable is $1.10 million

Debt

Total debt

$1.51M
VVOS annual total debt is $1.51 million

Total debt 1-year change

-24.21%
VVOS annual total debt is down -24.21% year-on-year

Long term debt

$1.03M
VVOS annual long term debt is $1.03 million

Short term debt

$477.00K
VVOS annual short term debt is $477.00 thousand

Equity & Capital

Shareholders equity

$7.95M
VVOS annual stockholders equity is $7.95 million

Book value

$7.95M
VVOS annual book value is $7.95 million

Retained earnings

-$104.19M
VVOS annual retained earnings is -$104.19 million

Working capital

$2.50M
VVOS annual working capital is $2.50 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$12.69M
VVOS annual cash flow from operations is -$12.69 million

Cash from operations 1-year change

-6.24%
VVOS annual cash flow from operations is down -6.24% year-on-year

Cash from investing

-$568.00K
VVOS annual cash flow from investing activities is -$568.00 thousand

Cash from investing 1-year change

+33.41%
VVOS annual cash flow from investing activities is up +33.41% year-on-year

Cash from financing

$17.88M
VVOS annual cash flow from financing activities is $17.88 million

Cash from financing 1-year change

+63.65%
VVOS annual cash flow from financing activities is up +63.65% year-on-year

CAPEX

CAPEX

$568.00K
VVOS annual capital expenditures is $568.00 thousand

CAPEX 1-year change

-29.27%
VVOS annual capital expenditures is down -29.27% year-on-year

Free Cash Flow

Free cash flow

-$13.26M
VVOS annual free cash flow is -$13.26 million

Free cash flow 1-year change

-4%
VVOS annual free cash flow is down -4% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

60.00%
VVOS annual gross profit margin is 60.00%

Operating margin

-74.32%
VVOS annual operating profit margin is -74.32%

Net margin

-74.09%
VVOS annual net profit margin is -74.09%

ROA & ROE

ROA

-85.62%
VVOS annual return on assets is -85.62%

ROE

-266.25%
VVOS annual return on equity is -266.25%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
VVOS price to earnings ratio value is unknown

PE ratio Sector rank

-
VVOS price to earnings ratio is unknown

PB Ratio

PB ratio

1.73
VVOS price to book ratio is 1.73

PB ratio Sector rank

59.21%
VVOS price to book ratio is higher than 59.21% of companies in Healthcare sector

PS Ratio

PS ratio

0.91
VVOS price to sales ratio is 0.91

PS ratio Sector rank

26.03%
VVOS price to sales ratio is higher than 26.03% of companies in Healthcare sector

Enterprise value

Enterprise value

$8.97M
VVOS enterprise value is $8.97 million

Enterprise value Sector rank

24.36%
VVOS enterprise value is higher than 24.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.85
VVOS EV/EBITDA is -0.85

EV/EBITDA Sector rank

44.83%
VVOS EV/EBITDA is higher than 44.83% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.50
VVOS annual current ratio is 1.50

Quick ratio

-
VVOS annual quick ratio value is unknown

Leverage

Debt to equity

0.00
VVOS annual debt to equity ratio is 0.00

Interest coverage ratio

-
VVOS annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

2
VVOS piotroski f-score is 2

Altman Z-Score

-9.65
VVOS altman z-score is -9.65

Analyst ratings

Recent major analysts updates

Nov 20, 24 Ascendiant Capital
Buy
Nov 19, 24 Alliance Global Partners
Buy
Aug 20, 24 Ascendiant Capital
Buy
Jan 17, 23 Ascendiant Capital
Buy
Aug 13, 21 Roth Capital
Buy
May 18, 21 Roth Capital
Buy
Jan 11, 21 Craig-Hallum
Buy
Jan 5, 21 Roth Capital
Buy

Institutional Ownership

Similar stocks

Abpro (ABP)
BNGO logo
Bionano Genomics (BNGO)
CING logo
Cingulate (CING)
AXLA logo
Axcella Health (AXLA)
CLDI logo
Calidi Biotherapeutics (CLDI)
PHGE logo
BiomX (PHGE)
AXDX logo
Accelerate Diagnostics (AXDX)
LPTX logo
Leap Therapeutics (LPTX)
PMD logo
Psychemedics (PMD)
  • What is the ticker symbol for Vivos Therapeutics?
  • Does Vivos Therapeutics pay dividends?
  • What sector is Vivos Therapeutics in?
  • What industry is Vivos Therapeutics in?
  • What country is Vivos Therapeutics based in?
  • When did Vivos Therapeutics go public?
  • Is Vivos Therapeutics in the S&P 500?
  • Is Vivos Therapeutics in the NASDAQ 100?
  • Is Vivos Therapeutics in the Dow Jones?
  • When was Vivos Therapeutics's last earnings report?
  • When does Vivos Therapeutics report earnings?
  • Should I buy Vivos Therapeutics stock now?

What is the ticker symbol for Vivos Therapeutics?

The ticker symbol for Vivos Therapeutics is NASDAQ:VVOS

Does Vivos Therapeutics pay dividends?

No, Vivos Therapeutics does not pay dividends

What sector is Vivos Therapeutics in?

Vivos Therapeutics is in the Healthcare sector

What industry is Vivos Therapeutics in?

Vivos Therapeutics is in the Medical Devices industry

What country is Vivos Therapeutics based in?

Vivos Therapeutics is headquartered in United States

When did Vivos Therapeutics go public?

Vivos Therapeutics's initial public offering (IPO) was on December 11, 2020

Is Vivos Therapeutics in the S&P 500?

No, Vivos Therapeutics is not included in the S&P 500 index

Is Vivos Therapeutics in the NASDAQ 100?

No, Vivos Therapeutics is not included in the NASDAQ 100 index

Is Vivos Therapeutics in the Dow Jones?

No, Vivos Therapeutics is not included in the Dow Jones index

When was Vivos Therapeutics's last earnings report?

Vivos Therapeutics's most recent earnings report was on Mar 31, 2025

When does Vivos Therapeutics report earnings?

The next expected earnings date for Vivos Therapeutics is May 14, 2025

Should I buy Vivos Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page